FDA approves remote heart monitoring device

Eko Devices, a tech company in Berkeley, California, has received U.S. Food and Drug Administration (FDA) approval for its combined digital stethoscope and electrocardiogram that can be used from home, reports Qmed.

The handheld device links to a smartphone app that wirelessly transmits heart sounds and electrical activity to a physician for remote monitoring. The device can help reduce heart failure and atrial fibrillation. Eko is the company to release one of the first smart stethoscopes.

“I’m excited about the device,” said University of California, San Francisco cardiologist John Chorba. “I see it primarily as a great way to capture the heart sounds and some electrocardiographic findings in a very user-friendly way.”

To read the full story, follow the link below.